BIOMAT Database Logo BIOMAT Database Logo

Temporary heterotopic auxiliary liver transplantation for fulminant hepatitis B. 1995

B van Hoek, and J Ringers, and A C Kroes, and J H van Krieken, and W D van Schelven, and A A Masclee, and L G van Krikken-Hogenberk, and H R Haak, and C B Lamers, and O T Terpstra
Department of Gastroenterology and Hepatology, Diaconess Hospital Eindhoven, The Netherlands.

OBJECTIVE Orthotopic liver transplantation has been shown to improve survival in fulminant hepatic failure. However, after orthotopic liver transplantation life-long immunosuppression is necessary and graft complications may occur. METHODS We employed heterotopic auxiliary liver transplantation in a 26-year-old man with fulminant hepatic failure due to hepatitis B virus infection. RESULTS From a comatose state with seizures and decerebrate posturing, the patient woke up the day after heterotopic auxiliary liver transplantation. The graft functioned sufficiently. After 2 weeks, when peritonitis developed, immunosuppression was stopped since the native liver was recovering as shown by serial HIDA scans, liver biopsies, clotting parameters and serum bilirubin. When severe rejection of the graft developed 2 weeks later, and the peritonitis had been treated successfully, the native liver had recovered sufficiently to allow the graft to be removed. Now, more than 1 year after heterotopic auxiliary liver transplantation, the patient is free from medication and he is immune for hepatitis B virus, his liver tests have returned to normal and he has regained his normal life. CONCLUSIONS Temporary heterotopic auxiliary liver transplantation for fulminant hepatitis B is feasible.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D006501 Hepatic Encephalopathy A syndrome characterized by central nervous system dysfunction in association with LIVER FAILURE, including portal-systemic shunts. Clinical features include lethargy and CONFUSION (frequently progressing to COMA); ASTERIXIS; NYSTAGMUS, PATHOLOGIC; brisk oculovestibular reflexes; decorticate and decerebrate posturing; MUSCLE SPASTICITY; and bilateral extensor plantar reflexes (see REFLEX, BABINSKI). ELECTROENCEPHALOGRAPHY may demonstrate triphasic waves. (From Adams et al., Principles of Neurology, 6th ed, pp1117-20; Plum & Posner, Diagnosis of Stupor and Coma, 3rd ed, p222-5) Encephalopathy, Hepatic,Portosystemic Encephalopathy,Encephalopathy, Hepatocerebral,Encephalopathy, Portal-Systemic,Encephalopathy, Portosystemic,Fulminant Hepatic Failure with Cerebral Edema,Hepatic Coma,Hepatic Stupor,Hepatocerebral Encephalopathy,Portal-Systemic Encephalopathy,Coma, Hepatic,Comas, Hepatic,Encephalopathies, Hepatic,Encephalopathies, Hepatocerebral,Encephalopathies, Portal-Systemic,Encephalopathies, Portosystemic,Encephalopathy, Portal Systemic,Hepatic Comas,Hepatic Encephalopathies,Hepatic Stupors,Hepatocerebral Encephalopathies,Portal Systemic Encephalopathy,Portal-Systemic Encephalopathies,Portosystemic Encephalopathies,Stupor, Hepatic,Stupors, Hepatic
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001663 Bilirubin A bile pigment that is a degradation product of HEME. Bilirubin IX alpha,Bilirubin, (15E)-Isomer,Bilirubin, (4E)-Isomer,Bilirubin, (4E,15E)-Isomer,Bilirubin, Calcium Salt,Bilirubin, Disodium Salt,Bilirubin, Monosodium Salt,Calcium Bilirubinate,Hematoidin,delta-Bilirubin,Bilirubinate, Calcium,Calcium Salt Bilirubin,Disodium Salt Bilirubin,Monosodium Salt Bilirubin,Salt Bilirubin, Calcium,delta Bilirubin

Related Publications

B van Hoek, and J Ringers, and A C Kroes, and J H van Krieken, and W D van Schelven, and A A Masclee, and L G van Krikken-Hogenberk, and H R Haak, and C B Lamers, and O T Terpstra
Auxiliary heterotopic liver transplantation with portal vein arterialization for fulminant hepatic failure.
November 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,
B van Hoek, and J Ringers, and A C Kroes, and J H van Krieken, and W D van Schelven, and A A Masclee, and L G van Krikken-Hogenberk, and H R Haak, and C B Lamers, and O T Terpstra
Auxiliary Heterotopic Liver Transplantation.
January 1990, The National medical journal of India,
B van Hoek, and J Ringers, and A C Kroes, and J H van Krieken, and W D van Schelven, and A A Masclee, and L G van Krikken-Hogenberk, and H R Haak, and C B Lamers, and O T Terpstra
[Auxiliary heterotopic liver transplantation].
July 1991, Nederlands tijdschrift voor geneeskunde,
B van Hoek, and J Ringers, and A C Kroes, and J H van Krieken, and W D van Schelven, and A A Masclee, and L G van Krikken-Hogenberk, and H R Haak, and C B Lamers, and O T Terpstra
Auxiliary heterotopic liver transplantation.
June 1988, Transplantation,
B van Hoek, and J Ringers, and A C Kroes, and J H van Krieken, and W D van Schelven, and A A Masclee, and L G van Krikken-Hogenberk, and H R Haak, and C B Lamers, and O T Terpstra
[Temporary auxiliary orthotopic transplantation of a reduced liver for fulminant hepatitis. A successful case in a child].
January 1993, Chirurgie; memoires de l'Academie de chirurgie,
B van Hoek, and J Ringers, and A C Kroes, and J H van Krieken, and W D van Schelven, and A A Masclee, and L G van Krikken-Hogenberk, and H R Haak, and C B Lamers, and O T Terpstra
Orthotopic liver transplantation for fulminant hepatitis B.
June 2000, World journal of gastroenterology,
B van Hoek, and J Ringers, and A C Kroes, and J H van Krieken, and W D van Schelven, and A A Masclee, and L G van Krikken-Hogenberk, and H R Haak, and C B Lamers, and O T Terpstra
Clinical liver heterotopic (auxiliary) transplantation.
November 1973, Surgery,
B van Hoek, and J Ringers, and A C Kroes, and J H van Krieken, and W D van Schelven, and A A Masclee, and L G van Krikken-Hogenberk, and H R Haak, and C B Lamers, and O T Terpstra
Heterotopic auxiliary canine liver transplantation.
March 1972, Canadian journal of surgery. Journal canadien de chirurgie,
B van Hoek, and J Ringers, and A C Kroes, and J H van Krieken, and W D van Schelven, and A A Masclee, and L G van Krikken-Hogenberk, and H R Haak, and C B Lamers, and O T Terpstra
Living related heterotopic auxiliary partial liver transplantation for extremely small-for-size graft in fulminant liver failure.
January 2003, Hepato-gastroenterology,
B van Hoek, and J Ringers, and A C Kroes, and J H van Krieken, and W D van Schelven, and A A Masclee, and L G van Krikken-Hogenberk, and H R Haak, and C B Lamers, and O T Terpstra
Auxiliary partial orthotopic liver transplantation for fulminant hepatitis. The Paul Brousse experience.
December 1996, Annals of surgery,
Copied contents to your clipboard!